Cite
Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers.
MLA
Cecchi, M., et al. “Validation of a Suite of ERP and QEEG Biomarkers in a Pre-Competitive, Industry-Led Study in Subjects with Schizophrenia and Healthy Volunteers.” Schizophrenia Research, vol. 254, Apr. 2023, pp. 178–89. EBSCOhost, https://doi.org/10.1016/j.schres.2023.02.018.
APA
Cecchi, M., Adachi, M., Basile, A., Buhl, D. L., Chadchankar, H., Christensen, S., Christian, E., Doherty, J., Fadem, K. C., Farley, B., Forman, M. S., Honda, S., Johannesen, J., Kinon, B. J., Klamer, D., Marino, M. J., Missling, C., O’Donnell, P., Piser, T., … Ereshefsky, L. (2023). Validation of a suite of ERP and QEEG biomarkers in a pre-competitive, industry-led study in subjects with schizophrenia and healthy volunteers. Schizophrenia Research, 254, 178–189. https://doi.org/10.1016/j.schres.2023.02.018
Chicago
Cecchi, M, M Adachi, A Basile, D L Buhl, H Chadchankar, S Christensen, E Christian, et al. 2023. “Validation of a Suite of ERP and QEEG Biomarkers in a Pre-Competitive, Industry-Led Study in Subjects with Schizophrenia and Healthy Volunteers.” Schizophrenia Research 254 (April): 178–89. doi:10.1016/j.schres.2023.02.018.